ABCA1: Phospholipid-transporting ATPase ABCA1
Catalyzes the translocation of specific phospholipids from the cytoplasmic to the extracellular/lumenal leaflet of membrane coupled to the hydrolysis of ATP.
- Drugs that act on it: 1
- Approved: 1
- In phases 1 to 3: 0
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on ABCA1, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 1
The landscape
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.Open trials
The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 3 in all, from ClinicalTrials.gov.| Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke | Probucol | — | Recruiting | Xuanwu Hospital, Beijing | Sep 19, 2024 |
| Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis | Probucol | Phase 3 | Recruiting | First Affiliated Hospital of Wannan Medical College | Jan 26, 2024 |
| The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques | Probucol | Phase 4 | Recruiting | General Hospital of Shenyang Military Region | Nov 27, 2018 |
Diseases most associated with it
Open Targets association score, 0 to 1; all associations- Tangier disease
- 0.84
- Hypoalphalipoproteinemia, primary, 1
- 0.75
- Hypoalphalipoproteinemia
- 0.61
- Metabolic disease
- 0.56
- Glaucoma
- 0.55
- Hyperlipidemia
- 0.51
- Alcohol drinking
- 0.51
- Coronary artery disorder
- 0.49
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2362986, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt O95477, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets